share_log

永泰生物-B:建議根據一般授權發行可換股債券及一名主要股東訂立股份認購權契據

Immunotech Biopharm Ltd-B: PROPOSED ISSUE OF CONVERTIBLE BONDSUNDER GENERAL MANDATEANDCALL OPTION DEED BYA SUBSTANTIAL SHAREHOLDER

HKEX ·  Oct 30, 2022 07:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more